FDA
approval
· 2017-09-29
FDA Approved: DEFEROXAMINE MESYLATE — Original Application (Apotex Corp.)
Summary
FDA approved Apotex Corp's generic deferoxamine mesylate (Deferoxamine Mesylate) under an original ANDA for the treatment of iron overload due to transfusions a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for DEFEROXAMINE MESYLATE (DEFEROXAMINE MESYLATE)